Tokio Marine Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $740K | Hold |
13,100
| – | – | 0.03% | 419 |
|
|
2025
Q4 | $779K | Sell |
13,100
-9,438
| -42% | -$514K | 0.03% | 416 |
|
|
2025
Q3 | $1.22M | Sell |
22,538
-1,100
| -5% | -$62.9K | 0.04% | 299 |
|
|
2025
Q2 | $1.3M | Buy |
23,638
+1,115
| +5% | +$65.7K | 0.05% | 280 |
|
|
2025
Q1 | $1.59M | Buy |
22,523
+197
| +0.9% | +$13.3K | 0.06% | 241 |
|
|
2024
Q4 | $1.47M | Buy |
22,326
+1,221
| +6% | +$81.8K | 0.05% | 255 |
|
|
2024
Q3 | $1.48M | Buy |
21,105
+173
| +0.8% | +$14.5K | 0.07% | 220 |
|
|
2024
Q2 | $1.72M | Buy |
20,932
+438
| +2% | +$36.5K | 0.08% | 170 |
|
|
2024
Q1 | $1.79M | Sell |
20,494
-684
| -3% | -$61.2K | 0.09% | 166 |
|
|
2023
Q4 | $2.04M | Sell |
21,178
-272
| -1% | -$24.1K | 0.11% | 137 |
|
|
2023
Q3 | $1.9M | Sell |
21,450
-1,048
| -5% | -$93.2K | 0.12% | 127 |
|
|
2023
Q2 | $1.95M | Sell |
22,498
-928
| -4% | -$87.3K | 0.12% | 118 |
|
|
2023
Q1 | $2.28M | Buy |
23,426
+613
| +3% | +$63.5K | 0.16% | 102 |
|
|
2022
Q4 | $2.36M | Sell |
22,813
-703
| -3% | -$66K | 0.18% | 97 |
|
|
2022
Q3 | $1.99M | Buy |
23,516
+358
| +2% | +$31.9K | 0.17% | 86 |
|
|
2022
Q2 | $1.92M | Sell |
23,158
-5,057
| -18% | -$403K | 0.17% | 91 |
|
|
2022
Q1 | $2.17M | Buy |
28,215
+970
| +4% | +$81.2K | 0.17% | 87 |
|
|
2021
Q4 | $2.41M | Buy |
27,245
+1,441
| +6% | +$119K | 0.19% | 77 |
|
|
2021
Q3 | $1.99M | Sell |
25,804
-3
| -0% | -$237 | 0.18% | 78 |
|
|
2021
Q2 | $2.15M | Sell |
25,807
-805
| -3% | -$63.8K | 0.2% | 63 |
|
|
2021
Q1 | $2.01M | Buy |
26,612
+272
| +1% | +$22.2K | 0.21% | 66 |
|
|
2020
Q4 | $2.31M | Sell |
26,340
-788
| -3% | -$62.5K | 0.25% | 55 |
|
|
2020
Q3 | $2.06M | Sell |
27,128
-1,788
| -6% | -$181K | 0.26% | 52 |
|
|
2020
Q2 | $3.57M | Sell |
28,916
-1,035
| -3% | -$103K | 0.51% | 45 |
|
|
2020
Q1 | $2.53M | Buy |
29,951
+195
| +0.7% | +$16.8K | 0.43% | 49 |
|
|
2019
Q4 | $2.52M | Buy |
29,756
+91
| +0.3% | +$6.87K | 0.38% | 48 |
|
|
2019
Q3 | $2M | Buy |
29,665
+2,428
| +9% | +$187K | 0.33% | 52 |
|
|
2019
Q2 | $2.33M | Buy |
27,237
+95
| +0.4% | +$8.13K | 0.41% | 54 |
|
|
2019
Q1 | $2.41M | Buy |
27,142
+144
| +0.5% | +$13.3K | 0.45% | 50 |
|
|
2018
Q4 | $2.3M | Buy |
26,998
+89
| +0.3% | +$8.47K | 0.46% | 54 |
|
|
2018
Q3 | $2.61M | Sell |
26,909
-95
| -0.4% | -$9.48K | 0.46% | 53 |
|
|
2018
Q2 | $2.54M | Sell |
27,004
-408
| -1% | -$35.7K | 0.47% | 52 |
|
|
2018
Q1 | $2.22M | Sell |
27,412
-443
| -2% | -$38K | 0.39% | 57 |
|
|
2017
Q4 | $2.48M | Sell |
27,855
-404
| -1% | -$35.1K | 0.38% | 67 |
|
|
2017
Q3 | $2.63M | Sell |
28,259
-639
| -2% | -$56.5K | 0.4% | 71 |
|
|
2017
Q2 | $2.63M | Sell |
28,898
-1,862
| -6% | -$169K | 0.38% | 73 |
|
|
2017
Q1 | $2.7M | Sell |
30,760
-7,296
| -19% | -$649K | 0.35% | 82 |
|
|
2016
Q4 | $3.15M | Sell |
38,056
-1,062
| -3% | -$91.3K | 0.36% | 78 |
|
|
2016
Q3 | $3.62M | Sell |
39,118
-2,227
| -5% | -$210K | 0.39% | 71 |
|
|
2016
Q2 | $3.22M | Sell |
41,345
-143
| -0.3% | -$12.2K | 0.33% | 79 |
|
|
2016
Q1 | $3.42M | Buy |
41,488
+3,448
| +9% | +$281K | 0.34% | 77 |
|
|
2015
Q4 | $3.98M | Sell |
38,040
-1,324
| -3% | -$138K | 0.44% | 66 |
|
|
2015
Q3 | $4.15M | Sell |
39,364
-4,500
| -10% | -$601K | 0.43% | 69 |
|
|
2015
Q2 | $6M | Buy |
43,864
+14,047
| +47% | +$1.74M | 0.59% | 49 |
|
|
2015
Q1 | $3.72M | Sell |
29,817
-18,712
| -39% | -$1.98M | 0.34% | 75 |
|
|
2014
Q4 | $4.39M | Sell |
48,529
-23,023
| -32% | -$1.91M | 0.38% | 68 |
|
|
2014
Q3 | $5.16M | Sell |
71,552
-1,700
| -2% | -$112K | 0.37% | 70 |
|
|
2014
Q2 | $4.56M | Buy |
73,252
+11,900
| +19% | +$719K | 0.31% | 74 |
|
|
2014
Q1 | $4.18M | Sell |
61,352
-2,200
| -3% | -$162K | 0.27% | 83 |
|
|
2013
Q4 | $4.47M | Sell |
63,552
-3,200
| -5% | -$217K | 0.28% | 80 |
|
|
2013
Q3 | $4.82M | Sell |
66,752
-8,800
| -12% | -$585K | 0.31% | 82 |
|
|
2013
Q2 | $4.21M | Buy |
+75,552
| New | +$4.71M | 0.27% | 90 |
|
Other funds holding BMRN
VCM
VPM
Tokio Marine Asset Management's BMRN Position: Q1 2026 in Review
Tokio Marine Asset Management held its BioMarin Pharmaceuticals (BMRN) position steady in Q1 2026 at 13,100 shares worth $740K. The position accounts for 0.03% of the portfolio, ranked #419.
Tokio Marine Asset Management first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $6M in Q2 2015. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Tokio Marine Asset Management held 13,100 shares of BioMarin Pharmaceuticals worth $740K as of Q1 2026.
- Tokio Marine Asset Management left its BioMarin Pharmaceuticals share count unchanged in Q1 2026.
- BioMarin Pharmaceuticals made up 0.03% of Tokio Marine Asset Management's portfolio in Q1 2026, its #419 holding.
- Tokio Marine Asset Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Tokio Marine Asset Management's BioMarin Pharmaceuticals position peaked at $6M in Q2 2015.
- 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Tokio Marine Asset Management's 13F filing for Q1 2026, filed 13 May 2026.